PetMed Express (NASDAQ:PETS) Share Price Passes Above 200 Day Moving Average – Here’s What Happened

Shares of PetMed Express, Inc. (NASDAQ:PETS) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.15 and traded as high as $4.82. PetMed Express shares last traded at $4.77, with a volume of 131,466 shares traded.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th.

PetMed Express Stock Performance

The company’s fifty day moving average is $5.04 and its 200-day moving average is $4.15. The company has a market capitalization of $98.56 million, a PE ratio of -79.50 and a beta of 0.69.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.17. The company had revenue of $59.57 million for the quarter, compared to analysts’ expectations of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. On average, sell-side analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.

Insider Activity at PetMed Express

In related news, Director Leslie C.G. Campbell acquired 15,000 shares of PetMed Express stock in a transaction on Wednesday, December 4th. The stock was acquired at an average price of $5.38 per share, for a total transaction of $80,700.00. Following the purchase, the director now owns 70,000 shares of the company’s stock, valued at approximately $376,600. This represents a 27.27 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On PetMed Express

Several institutional investors and hedge funds have recently modified their holdings of PETS. Point72 DIFC Ltd purchased a new position in PetMed Express during the second quarter worth about $34,000. Marshall Wace LLP acquired a new stake in PetMed Express during the 2nd quarter worth $46,000. Independent Advisor Alliance acquired a new position in shares of PetMed Express during the 3rd quarter worth $106,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of PetMed Express in the 2nd quarter valued at about $135,000. Finally, Sei Investments Co. lifted its stake in shares of PetMed Express by 8.3% in the second quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock valued at $179,000 after purchasing an additional 3,400 shares during the period. Hedge funds and other institutional investors own 73.33% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.